Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure.
about
Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Entresto (Sacubitril/Valsartan ...... r Patients with Heart Failure.
@ast
Entresto (Sacubitril/Valsartan ...... r Patients with Heart Failure.
@en
type
label
Entresto (Sacubitril/Valsartan ...... r Patients with Heart Failure.
@ast
Entresto (Sacubitril/Valsartan ...... r Patients with Heart Failure.
@en
prefLabel
Entresto (Sacubitril/Valsartan ...... r Patients with Heart Failure.
@ast
Entresto (Sacubitril/Valsartan ...... r Patients with Heart Failure.
@en
P2860
P1476
Entresto (Sacubitril/Valsartan ...... r Patients with Heart Failure.
@en
P2093
Loretta Fala
P2860
P304
P577
2015-09-01T00:00:00Z